These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11581400)

  • 21. Homeostatic role of IL-7 in HIV-1 infected children on HAART: association with immunological and virological parameters.
    Resino S; Galán I; Correa R; Pajuelo L; Bellón JM; Muñoz-Fernández MA
    Acta Paediatr; 2005 Feb; 94(2):170-7. PubMed ID: 15981750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.
    Beq S; Delfraissy JF; Theze J
    Eur Cytokine Netw; 2004; 15(4):279-89. PubMed ID: 15627636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target cell populations of human immunodeficiency virus type 1 in peripheral blood lymphocytes with different chemokine receptors at various stages of disease progression.
    Auewarakul P; Sangsiriwut K; Suwanagool S; Wasi C
    J Virol; 2001 Jul; 75(14):6384-91. PubMed ID: 11413305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells.
    Vanham G; van Tendeloo V; Willems B; Penne L; Kestens L; Beirnaert E; Fransen K; Heyndrickx L; Zhong P; Davis D; Berneman Z; van Der Groen G; Van Bockstaele D
    J Med Virol; 2000 Mar; 60(3):300-12. PubMed ID: 10630963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection.
    Koot M; van 't Wout AB; Kootstra NA; de Goede RE; Tersmette M; Schuitemaker H
    J Infect Dis; 1996 Feb; 173(2):349-54. PubMed ID: 8568295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
    Schuitemaker H; Kootstra NA; de Goede RE; de Wolf F; Miedema F; Tersmette M
    J Virol; 1991 Jan; 65(1):356-63. PubMed ID: 1985204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.
    Koot M; Keet IP; Vos AH; de Goede RE; Roos MT; Coutinho RA; Miedema F; Schellekens PT; Tersmette M
    Ann Intern Med; 1993 May; 118(9):681-8. PubMed ID: 8096374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-syncytium-inducing HIV type 1 isolated from infected individuals replicates in MT-2 cells.
    Forte SE; Byron KS; Sullivan JL; Somasundaran M
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1613-8. PubMed ID: 7888220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains.
    Lin YL; Portales P; Segondy M; Baillat V; de Boever CM; Le Moing V; Réant B; Montes B; Clot J; Reynes J; Corbeau P
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):530-6. PubMed ID: 16044003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse.
    Kaneshima H; Su L; Bonyhadi ML; Connor RI; Ho DD; McCune JM
    J Virol; 1994 Dec; 68(12):8188-92. PubMed ID: 7966610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype.
    Nakayama EE; Hoshino Y; Xin X; Liu H; Goto M; Watanabe N; Taguchi H; Hitani A; Kawana-Tachikawa A; Fukushima M; Yamada K; Sugiura W; Oka SI; Ajisawa A; Sato H; Takebe Y; Nakamura T; Nagai Y; Iwamoto A; Shioda T
    J Virol; 2000 Jun; 74(12):5452-9. PubMed ID: 10823849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.
    Connor RI; Sheridan KE; Ceradini D; Choe S; Landau NR
    J Exp Med; 1997 Feb; 185(4):621-8. PubMed ID: 9034141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy.
    Delobel P; Sandres-Sauné K; Cazabat M; Pasquier C; Marchou B; Massip P; Izopet J
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):382-92. PubMed ID: 15764954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1.
    Connor RI; Paxton WA; Sheridan KE; Koup RA
    J Virol; 1996 Dec; 70(12):8758-64. PubMed ID: 8971004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a role of T-helper type 2 cytokines in the acquisition of human immunodeficiency virus syncytium-inducing phenotype.
    Torres Y; Medrano FJ; Rey C; Calderón EJ; Sánchez-Quijano A; Lissen E; Leal M
    Eur J Clin Invest; 1998 Nov; 28(11):930-6. PubMed ID: 9824438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users.
    Yu XF; Wang Z; Vlahov D; Markham RB; Farzadegan H; Margolick JB
    J Infect Dis; 1998 Aug; 178(2):388-96. PubMed ID: 9697718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.